| dc.creator |
Işık, Ümit |
|
| dc.creator |
Kılıç, Faruk |
|
| dc.creator |
Bozkurt, Mustafa |
|
| dc.creator |
Doğuç, Duygu |
|
| dc.creator |
Demirdaş, Arif |
|
| dc.date |
2020-03-31T21:00:00Z |
|
| dc.date.accessioned |
2020-10-06T11:50:40Z |
|
| dc.date.available |
2020-10-06T11:50:40Z |
|
| dc.identifier |
f245afec-6baa-4f27-a7dc-a80802f8e36d |
|
| dc.identifier |
10.1016/j.jad.2020.01.117 |
|
| dc.identifier |
https://avesis.sdu.edu.tr/publication/details/f245afec-6baa-4f27-a7dc-a80802f8e36d/oai |
|
| dc.identifier.uri |
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/75961 |
|
| dc.description |
Background: The etiology in bipolar disorder has not been fully understanding. There are limited data regarding the relationship between the permeability of intestinal and blood-brain barrier (BBB), and bipolar disorder etiology. Zonulin is regarded as a non-invasive biomarker for intestinal permeability. Claudin-5 is an important part of BBB permeability. In this study, we assumed that there may be a deterioration in serum zonulin and claudin-5 levels in patients with bipolar disorder and this may affect the severity of the disease. |
|
| dc.language |
eng |
|
| dc.rights |
info:eu-repo/semantics/closedAccess |
|
| dc.title |
Serum zonulin and claudin-5 levels in patients with bipolar disorder |
|
| dc.type |
info:eu-repo/semantics/article |
|